New study tests Scope-Based lesion removal in western patients
NCT ID NCT02989818
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is tracking 300 adults who are already scheduled to have a procedure called endoscopic submucosal dissection (ESD) to remove abnormal growths in their digestive tract. Researchers want to see how often the lesion can be removed in one piece with clear margins, and how safe the procedure is. The goal is to gather real-world evidence on whether ESD works well in Western patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Endoscopic submucosal dissection (ESD) procedure
What this could lead to
If successful, this study could confirm that ESD is a safe and effective standard technique for removing early gastrointestinal lesions in Western patients, potentially reducing the need for more invasive surgery.
What could go wrong
This is an observational study, not a randomized trial, so it cannot prove ESD is better than other methods. Results may vary across centers and patient groups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOSCOPIC SUBMUCOSAL DISSECTION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Baylor College of Medicine
RECRUITINGHouston, Texas, 77030, United States
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
-
University of Florida
RECRUITINGGainesville, Florida, 32610, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact